SHEL.UK

2,875

-0.09%↓

SHEL.UK

2,875

-0.09%↓

SHEL.UK

2,875

-0.09%↓

SHEL.UK

2,875

-0.09%↓

SHEL.UK

2,875

-0.09%↓

DCC PLC

Затворен

СекторЕнергийни

5,220 -0.48

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

5180

Максимум

5260

Ключови измерители

By Trading Economics

Приходи

-116M

-4.1M

Продажби

-1.3B

7.4B

P/E

Средно за сектора

37.674

25.238

EPS

1.3

Дивидентна доходност

4.29

Марж на печалбата

-0.056

Служители

16,700

EBITDA

-113M

260M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+8.55% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

4.29%

4.00%

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-700M

4.2B

Предишно отваряне

5220.48

Предишно затваряне

5220

Настроения в новините

By Acuity

50%

50%

55 / 137 Класиране в Energy

DCC PLC Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

15.02.2026 г., 23:21 ч. UTC

Придобивния, сливания и поглъщания

Qube Agrees to Takeover by MAM-Led Consortium Valuing Its Equity at $6.51 Billion

15.02.2026 г., 23:45 ч. UTC

Пазарно говорене

Nikkei May Rise as Fears About AI Disruption Recede -- Market Talk

15.02.2026 г., 23:40 ч. UTC

Пазарно говорене

Gold Falls on Possible Position Adjustments -- Market Talk

15.02.2026 г., 23:06 ч. UTC

Печалби

Thai Beverage: Spirits, Beer Businesses Posted Satisfactory EBITDA Growth, Alongside Profit Margin Expansion>Y92.SG

15.02.2026 г., 23:04 ч. UTC

Печалби

Thai Beverage 1Q Beer Business EBITDA THB4.64B, Up 4.7% on Year>Y92.SG

15.02.2026 г., 23:04 ч. UTC

Печалби

Thai Beverage 1Q Spirits Business EBITDA THB8.50B, Up 6.9% on Year >Y92.SG

15.02.2026 г., 23:01 ч. UTC

Печалби

Thai Beverage 1Q EBITDA THB16.75B, Up 1.8% on Year >Y92.SG

15.02.2026 г., 23:01 ч. UTC

Печалби

Thai Beverage 1Q FY Sales Revenue THB86.70B, Down 6.0% on Year>Y92.SG

15.02.2026 г., 22:53 ч. UTC

Придобивния, сливания и поглъщания

Qube: MAM-Led Offer Implies A$11.7 Billion Enterprise Value

15.02.2026 г., 22:53 ч. UTC

Придобивния, сливания и поглъщания

Qube: UniSuper to Transfer 15.07% Stake to Equivalent Ownership of Consortium Holding Structure

15.02.2026 г., 22:52 ч. UTC

Придобивния, сливания и поглъщания

Qube Shareholders to Receive A$5.20/Share in Cash

15.02.2026 г., 22:52 ч. UTC

Придобивния, сливания и поглъщания

Qube Holdings Agrees to Takeover by Macquarie Asset Management-Led Consortium

15.02.2026 г., 22:22 ч. UTC

Придобивния, сливания и поглъщания

BlueScope CEO Tania Archibald Speaking on a Call With Media

15.02.2026 г., 22:17 ч. UTC

Придобивния, сливания и поглъщания

BlueScope CEO: Stresses Whyalla Project Would Have to Make Sense to Shareholders

15.02.2026 г., 22:16 ч. UTC

Придобивния, сливания и поглъщания

BlueScope CEO: Some Job Cuts Inevitable to Ensure Company is Competitive

15.02.2026 г., 22:14 ч. UTC

Придобивния, сливания и поглъщания

BlueScope CEO: Higher Returns Tied to End of Capital Investment Program

15.02.2026 г., 22:14 ч. UTC

Придобивния, сливания и поглъщания

BlueScope Steel CEO: Higher Returns After Rebuffed Takeover Bid a 'Natural Coincidence'

15.02.2026 г., 20:48 ч. UTC

Печалби

BlueScope: Will Now Target Net Debt of Up to A$1.5 Billion; Will Surpass as Needed

15.02.2026 г., 20:47 ч. UTC

Печалби

BlueScope: Expects Full Benefits of Further A$150M Cost Savings in FY 2027

15.02.2026 г., 20:46 ч. UTC

Печалби

BlueScope: Recorded Net Annualized Cost Improvements of A$190 Million in 1H

15.02.2026 г., 20:45 ч. UTC

Печалби

BlueScope Expects a One-Third Lower 2H Result From Asia Business Vs 1H

15.02.2026 г., 20:44 ч. UTC

Печалби

BlueScope Expects 15% Higher 2H Result From North America Business Vs 1H

15.02.2026 г., 20:44 ч. UTC

Печалби

BlueScope Expects Lower 2H Result From Australia Business Vs 1H

15.02.2026 г., 20:43 ч. UTC

Печалби

BlueScope Expects 2H Underlying Ebit of A$620 Million-A$700 Million

15.02.2026 г., 20:42 ч. UTC

Печалби

BlueScope Net Debt A$2.2 Million at Dec. 31

15.02.2026 г., 20:42 ч. UTC

Печалби

BlueScope 1H Underlying Ebit A$557.5 Million, Up 81% On-Year

15.02.2026 г., 20:41 ч. UTC

Печалби

BlueScope 1H Underlying Ebitda A$915.3 Million, Up 39% On-Year

15.02.2026 г., 20:40 ч. UTC

Печалби

BlueScope 1H Underlying Profit A$382.0 Million Vs A$176.4 Million Year Prior

15.02.2026 г., 20:40 ч. UTC

Печалби

BlueScope 1H Sales Revenue From Continuing Ops A$8.22 Billion, Up 4% On-Year

15.02.2026 г., 20:39 ч. UTC

Печалби

BlueScope Intends to Spend A$310 Million on Buyback, Or Other Returns if Share Repurchases Limited

Сравнение с други в отрасъла

Ценова промяна

DCC PLC Прогноза

Ценова цел

By TipRanks

8.55% нагоре

12-месечна прогноза

Среден 5,731.6 GBX  8.55%

Висок 6,500 GBX

Нисък 4,708 GBX

Според 5 анализатори от Wall Street, предложили 12-месечна ценова цел за DCC PLC през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

5 ratings

3

Купи

2

Задържане

0

Продай

Настроение

By Acuity

55 / 137 Класиране в Енергийни

Настроения в новините

Neutral

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно DCC PLC

DCC plc engages in the sales, marketing, and distribution of carbon energy solutions worldwide. The company operates through DCC Energy, DCC Healthcare, and DCC Technology segments. It sells transport and commercial fuels, heating oils and related products, liquid gas, refrigerants, electricity, and natural gas; sells and installs solar panels and energy efficiency solutions; operates a network of retail forecourts on motorways and in urban areas that provides fuel and EV charging; and offers multi-fuel bunkering and value add services for small/mid-sized fleets. It also offers medical devices for use in minimally invasive surgeries and related procedures in therapy areas, such as gastroenterology and urology; markets and sells medial consumables and equipment to including GPs, community healthcare providers, retail pharmacies, and emergency services; manufactures products for health and beauty brand owners; and develops and manufactures nutritional supplements and beauty products comprising tablets, capsules, gummies, soft gels, effervescents, powders, creams and liquids. In, addition it sells Pro Tech, which bring professional technologies together to enhance audio and visual experiences; Life Tech that provides technology to make high-quality lifestyles happen; and Info Tech to make faster connections happen. The company was incorporated in 1976 and is headquartered in Dublin, Ireland.
help-icon Live chat